Tris Pharma, Inc.
Clinical trials sponsored by Tris Pharma, Inc., explained in plain language.
-
New pain drug tested for recovery after cosmetic surgery
Symptom relief CompletedThis study tested whether a new pain medication called cebranopadol works better than a placebo (a dummy pill) for people with moderate to severe pain after a tummy tuck surgery. About 279 people who had the surgery were randomly assigned to receive either the real drug or the pl…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New drug tested to ease Post-Surgery pain
Symptom relief CompletedThis study tested whether a new drug called cebranopadol is safe and effective for reducing moderate to severe pain after bunion surgery. It compared the new drug to a placebo (a dummy pill) and an active pain medication in 240 people who had the surgery. The main goal was to see…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test if new pain drug is less addictive than oxycodone
Knowledge-focused CompletedThis study aimed to understand if a new drug called cebranopadol, when snorted, has a lower potential for abuse than the powerful painkiller oxycodone. Researchers compared how much 48 healthy recreational opioid users liked the feeling from cebranopadol, oxycodone, and a placebo…
Phase: PHASE1 • Sponsor: Tris Pharma, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC